SCHEMBL7290259

SCHEMBL7290259

CN(C)CCCN(C(=O)c1ccncc1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.59
KMT2A Q03164 2/20 0.59
ADRA2C P18825 1/20 0.56
ACHE P22303 1/20 0.50
PDE10A Q9Y233 2/20 0.48
HTT P42858 1/20 0.48
ALDH1A1 P00352 4/20 0.46
ADRB2 P07550 1/20 0.46
GAA P10253 1/20 0.44
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 1/20 0.43
MEN1 O00255 1/20 0.43
MLYCD O95822 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
LMNA P02545 1/20 0.42
NPC1 O15118 1/20 0.42
UBE2N P61088 1/20 0.42
RAD52 P43351 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7288882 0.90 ADRA2C (0.69) KMT2AADRA2CACHEHTTALDH1A1
SCHEMBL294596 0.78 SMN1; SMN2 (0.49) KDM4EKMT2AADRA2CHTTALDH1A1
SCHEMBL9735019 0.77 NPY2R (0.62) KDM4EKMT2AACHEL3MBTL1MAPT
SCHEMBL4483065 0.77 MLYCD (0.46) KDM4EKMT2AADRA2CACHEPDE10A
SCHEMBL18358943 0.77 HRH3 (0.48) KDM4EKMT2AADRA2CACHEALDH1A1
SCHEMBL23406121 0.77 TSHR (0.46) KMT2AADRA2CHTTTSHRMEN1
SCHEMBL29743815 0.77 TSHR (0.46) KMT2AADRA2CHTTTSHRMEN1
SCHEMBL3060251 0.76 TSHR (0.71) KDM4EKMT2AACHEHTTALDH1A1
SCHEMBL23405966 0.76 TSHR (0.45) KMT2AADRA2CTSHRMEN1NPC1
SCHEMBL29743800 0.76 TSHR (0.45) KMT2AADRA2CTSHRMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP claimed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP disclosed